Evaluation of BTX 1503 in Patients With Moderate to Severe Acne Vulgaris

NCT03573518 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

368

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne Vulgaris

Interventions

DRUG: BTX 1503
DRUG: Vehicle

Sponsor

Botanix Pharmaceuticals